Dulaglutide in Youth with Type 2 Diabetes (T2D) -Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial

被引：1
|
作者：
Arslanian, Silva A.
Cho, Jang Ik
Hannon, Tamara S.
Zeitler, Philip
Chao, Lily
Barrientos, Margarita
Boucher-Berry, Claudia C.
Bismuth, Elise
Dib, Sergio A.
Cox, David
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-5-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Outcomes of Type 2 Diabetes (T2D) Clustering Replicated in the DEVOTE Trial
    Kahkoska, Anna R.
    Hachmann-Nielsen, Elise
    Klein, Klara
    Kongsbak, Kristine G.
    Kvist, Kajsa
    Buse, John B.
    DIABETES, 2019, 68
  • [32] Circulating Metabolomic Biomarkers of Glycemic Control in Youth with Type 2 Diabetes (T2D)
    Chen, Zsu-Zsu
    Lu, Chang
    Shi, Xu
    Zheng, Shuning
    Wolfs, Danielle
    Bjornstad, Petter
    Gerszten, Robert E.
    Isganaitis, Elvira M.
    DIABETES, 2023, 72
  • [33] Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)
    Nauck, Michael
    Weinstock, Ruth S.
    Umpierrez, Guillermo E.
    Guerci, Bruno
    Skrivanek, Zachary
    Milicevic, Zvonko
    DIABETES CARE, 2014, 37 (08) : 2149 - 2158
  • [34] A Pilot, Randomized, Placebo-Controlled, Trial of Lithium in Spinocerebellar Ataxia Type 2
    Sacca, Francesco
    Marsili, Angela
    Pane, Chiara
    Brunetti, Arturo
    De Michele, Giuseppe
    Puorro, Giorgia
    Quarantelli, Mario
    Russo, Cinzia Valeria
    Salvatore, Elena
    Filla, Alessandro
    NEUROLOGY, 2013, 80
  • [35] Effect of Treating Vitamin D Deficiency in Uncontrolled Type 2 Diabetes: A Randomized, Placebo-Controlled Study
    Lo, Margaret C.
    Abushamat, Layla
    Mramba, Lazarus K.
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (04) : E441 - E451
  • [36] Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial
    Shestakova, Marina
    Kvasnikov, Boris
    Erina, Ekaterina
    Isachenko, Elena
    Andreev, Alexander
    Study Investigators
    BMJ OPEN DIABETES RESEARCH & CARE, 2023, 11 (03)
  • [37] Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial
    Brouwer, Annelies
    van Raalte, Daniel H.
    Hoang-Ton Nguyen
    Rutters, Femke
    van de Ven, Peter M.
    Elders, Petra J. M.
    Moll, Annette C.
    Van Someren, Eus J. W.
    Snoek, Frank J.
    Beekman, Aartjan T. F.
    Bremmer, Marijke A.
    DIABETES CARE, 2019, 42 (04) : 529 - 538
  • [38] Linagliptin Monotherapy Versus Initial Combination Therapy with Metformin in Patients with Newly Diagnosed Type 2 Diabetes (T2D): A Randomized Controlled Trial
    von Eynatten, Maximilian
    Ross, Stuart
    Caballero, Enrique
    Del Prato, Stefano
    Gallwitz, Baptist
    Lewis-D'Agostino, Diane
    Bailes, Zelie
    Thiemannt, Sandra
    Patel, Sanjay
    Woerle, Hans-Juergen
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [39] Factors Influencing Time to Case Ascertainment in Youth With Type 1 (T1D) and Type 2 Diabetes (T2D) in the SEARCH for Diabetes in Youth Study
    Crume, Tessa L.
    Hamman, Richard F.
    Isom, Scott
    Divers, Jasmin
    Mayer-Davis, Elizabeth
    Zhong, Wenze
    Saydah, Sharon H.
    Standiford, Debra A.
    Lawrence, Jean M.
    Pihoker, Catherine
    Dabelaa, Dana
    DIABETES, 2013, 62 : A412 - A412
  • [40] Efficacy and Safety of Dulaglutide versus Placebo and Exenatide in Type 2 Diabetes (AWARD-1)
    Wysham, Carol
    Blevins, Thomas
    Arakaki, Richard
    Colon, Gildred
    Garcia, Pedro
    Atisso, Charles
    Kuhstoss, Debra
    Scism-Bacon, Jamie
    Lakshmanan, Mark
    DIABETES, 2013, 62 : A16 - A16
12345